Label-free quantitative proteomics reveals differentially expressed proteins in high risk childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Label-free quantitative proteomics reveals differentially expressed proteins in high risk childhood acute lymphoblastic leukemia

Published:2017-01 Issue: Volume:150 Page:1-8
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Xu Gang,Li Zhijie,Wang Lili,Chen Fang,Chi Zuofei,Gu Min,li Shuang,Wu Di,Miao Jianing,Zhang Yi,Hao Liangchun,Fan Yang

Funder

Natural Science Foundation of Liaoning Province

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference57 articles.

1. Evolution of modern treatment of childhood acute leukemia and cancer: adventures and battles in the 1970s and 1980s;Ravindranath;Pediatr. Clin. N. Am.,2015

2. Differences in meiotic recombination rates in childhood acute lymphoblastic leukemia at an MHC class II hotspot close to disease associated haplotypes;Thompson;PLoS One,2014

3. Acute lymphoblastic leukemia;Pui;Lancet,2008

4. Management of adult andpaediatric acute lymphoblastic leukaemia in Asia: resource stratified guidelines from the Asian Oncology Summit 2013;Yeoh;Lancet Oncol.,2013

5. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?;Pui;Blood,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities;Pediatric Blood & Cancer;2024-03-31

2. Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities;Diagnostics;2023-08-24

3. Study on Tissue Homogenization Buffer Composition for Brain Mass Spectrometry-Based Proteomics;Biomedicines;2022-10-02

4. Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia;Therapeutic Advances in Hematology;2022-01

5. Potential Therapeutic Strategies for Targeting Y-Box-Binding Protein 1 in Cancers;Current Cancer Drug Targets;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3